EcoDrugPlus

Ribosomal Protein S8

Ensembl ID : ENSPNAG00000001823
Gene Symbol: RPS8
3 Cross references
326 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSPNAG00000011249
Gene Symbol: RPS9
3 Cross references
235 Possible Orthologues:

Ribosomal Protein Sa

Ensembl ID : ENSPNAG00000020586
Gene Symbol: RPSA
4 Cross references
516 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSPNAG00000003031
Gene Symbol: RPLP0
3 Cross references
397 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSPNAG00000017741
Gene Symbol: RPLP1
3 Cross references
382 Possible Orthologues:

Selectin E

Ensembl ID : ENSPNAG00000015156
Gene Symbol: SELE
1 Cross references
184 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-1-Like

Ensembl ID : ENSPNAG00000015243
Gene Symbol: LOC108438567
3 Cross references
246 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-3-Like

Ensembl ID : ENSPNAG00000014599
Gene Symbol: LOC108436897
3 Cross references
152 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSPNAG00000022554
Gene Symbol: SERPINC1
3 Cross references
201 Possible Orthologues:

Si:dkey-211g8.6

Ensembl ID : ENSPNAG00000001225
Gene Symbol: SI:DKEY-211G8.6
1 Cross references
320 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSPNAG00000006669
Gene Symbol: SIGMAR1
3 Cross references
205 Possible Orthologues:

Sirtuin 1

Ensembl ID : ENSPNAG00000007824
Gene Symbol: SIRT1
3 Cross references
155 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).